Redo cardiac surgery and atrial fibrillation: the ablation dilemma
Dominique Valerie Mabelle Verhaert,Dominik Linz,Bart Maesen
DOI: https://doi.org/10.21037/jtd-23-1741
2024-02-01
Journal of Thoracic Disease
Abstract:Dominique Valerie Mabelle Verhaert 1,2^ , Dominik Linz 1,2,3,4^ , Bart Maesen 5^ 1 Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands; 2 Department of Cardiology, Radboud University Medical Centre (Radboudumc), Nijmegen, the Netherlands; 3 Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 4 Centre for Heart Rhythm Disorders, Royal Adelaide Hospital, University of Adelaide, Adelaide, Australia; 5 Department of Cardiothoracic Surgery, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, the Netherlands ^ ORCID: Dominique Valerie Mabelle Verhaert, 0000-0003-3477-2589; Dominik Linz, 0000-0003-4893-0824; Bart Maesen, 0000-0001-8622-1450. Comment on: Kang Y, Choi JW, Kim JS, et al . The long-term outcomes of surgical ablation for atrial fibrillation during redo left-sided valvular surgery. J Thorac Dis 2023;15:2475-84. Keywords: Surgical ablation (SA); redo cardiac surgery; atrial fibrillation (AF) Submitted Nov 12, 2023. Accepted for publication Dec 05, 2023. Published online Jan 02, 2024. doi: 10.21037/jtd-23-1741 In patients undergoing cardiac surgery, atrial fibrillation (AF) is a frequent comorbidity. The arrhythmia is present in about half of patients undergoing mitral valve surgery and a quarter of aortic valve surgeries, partly due to structural abnormalities deriving from the underlying valvular disease (1). When present, AF is an independent predictor of a worse outcome after the surgery (2), and treatment of AF by concomitant surgical ablation (SA) ameliorates treatment outcomes. In the past decade, several randomized and observational studies found encouraging results of SA on restoration of sinus rhythm, quality of life, perioperative morbidity, and even mortality (3-6). Subsequently, SA for symptomatic AF patients concomitant with other cardiac surgery has been incorporated in the latest guideline recommendations (7,8). In contrast to primary cardiac surgical procedures, however, whether rhythm surgery should be performed concomitant to redo surgical procedures is not known. Redo surgeries are often technically more demanding due to the presence of scar tissue, adhesions, and altered anatomy. They generally last longer and complications occur more frequently than in primary procedures (9). Adding SA to these already long and complex procedures is therefore less attractive, and it is not supported by strong efficacy data. Until recently, only two studies compared SA with non-SA with a focus on redo surgery. The first was an older observational study that included 96 patients undergoing redo mitral valve operations (10). In the SA group, sinus rhythm was restored in two-thirds of patients. Perioperative complications were comparable for the SA and the non-SA group, and early and late mortality were not significantly different in this relatively small group. The second was primarily focused on patients with congenital heart disease, who represent an entirely different patient group (11). Other, larger studies evaluating the efficacy of concomitant SA often either excluded patients undergoing redo surgeries, or they composed a minority of the included population (ranging from 2–19%), with none of them describing the efficacy results of redo patients separately (6,12-14). The recent study by Kang et al. responded to this knowledge gap and added interesting new data to the landscape (15). This study presented described data on concomitant SA in the largest group of patients undergoing redo surgery so far. Patients undergoing a second or subsequent sternotomy for treatment of left-sided valvular disease, sometimes combined with right-sided valvular procedures or coronary artery bypass grafting, were retrospectively included. Those patients who had undergone concomitant SA were compared with those who did not. SA was performed at the discretion of the operator, and propensity score-adjusted multivariate analysis was performed between SA and non-SA patients. In total, 224 patients were included (73 patients in the SA group vs. 151 in the non-SA group) and followed for a median of 10 years after the surgery. The main conclusions were that patients who had undergone SA had better outcomes in terms of overall survival [hazard ratio (HR) =0.452; 95% confidence interval (CI): 0.218–0.936], sinus rhythm restoration (HR =0.505; 95% CI: 0.369–0.691), and a composite of thromboembolism and major bleeding (HR =0.338; 95% CI: 0.127–0.897). The authors should be congratulated for their achievement in composing the largest cohort of r -Abstract Truncated-
respiratory system